NCT05839652View on ClinicalTrials.gov

Treatment of Orthostatic Hypotension in SCI

PHASE4RecruitingINTERVENTIONAL

Enrollment

25

Participants

Timeline

Start Date

July 1, 2023

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions

Hypotension

Interventions

DRUG

Midodrine Hydrochloride

Determine best drug and dose to increase and stabilize SBP during orthostatic tilt

Trial Locations (2)

10468

RECRUITING

James J Peters VA Medical Center, The Bronx

07052

RECRUITING

Kessler Foundation, West Orange

Sponsors

Collaborators (1)

Kessler Foundation

All Listed Sponsors

collaborator

Kessler Foundation

OTHER

lead

James J. Peters Veterans Affairs Medical Center

FED

NCT05839652 - Treatment of Orthostatic Hypotension in SCI | Biotech Hunter | Biotech Hunter